Close Menu

molecular beacons

NEW YORK (GenomeWeb) – Researchers from the Stevens Institute of Technology have received $320,000 from the National Science Foundation to support the development of a multiplex molecular diagnostic system based on microgel-tethered molecular beacon hybridization probes.

Having recently secured funding from a private investor, moved to the San Francisco Bay Area, and obtained the rights to a key patent covering its core nucleic acid probe technology, molecular diagnostics startup QuanDx is now shifting its attention toward developing clinical ass

SAN FRANCISCO — Researchers from the University of Medicine and Dentistry of New Jersey and New Jersey Medical School this week unveiled a new qPCR-based mutation-detection chemistry at Cambridge Healthtech Institute's Molecular Medicine Tri-Conference held here.

Sigma Life Science, a division of Sigma Aldrich, is attempting to increase its share of the qPCR market by introducing for the first time pre-designed qPCR products to complement the custom product design work that has comprised the core of its business for the past several years

By Ben Butkus
Biosearch Technologies said today that it has acquired worldwide rights from the University of Medicine and Dentistry of New Jersey to patents covering "non-FRET" nucleic acid probe technology.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.